FULC
Price
$7.15
Change
-$0.26 (-3.51%)
Updated
Apr 17, 6:59 PM EST
27 days until earnings call
SLS
Price
$1.41
Change
+$0.05 (+3.68%)
Updated
Apr 17, 6:59 PM EST
22 days until earnings call
Ad is loading...

Compare predictions FULC vs SLS

Header iconFULC vs SLS Comparison
Open Charts FULC vs SLSBanner chart's image
Fulcrum Therapeutics
Price$7.15
Change-$0.26 (-3.51%)
Volume$204.76K
CapitalizationN/A
SELLAS Life Sciences Group
Price$1.41
Change+$0.05 (+3.68%)
Volume$416.03K
CapitalizationN/A
View a ticker or compare two or three
FULC vs SLS Comparison Chart

Loading...

FULCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SLSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
FULC vs. SLS commentary
Apr 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a StrongSell and SLS is a Hold.

COMPARISON
Comparison
Apr 18, 2024
Stock price -- (FULC: $7.41 vs. SLS: $1.36)
Brand notoriety: FULC and SLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 67% vs. SLS: 82%
Market capitalization -- FULC: $459.56M vs. SLS: $76.52M
FULC [@Biotechnology] is valued at $459.56M. SLS’s [@Biotechnology] market capitalization is $76.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $559.84B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 0 FA rating(s) are green whileSLS’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 0 green, 5 red.
  • SLS’s FA Score: 0 green, 5 red.
According to our system of comparison, both FULC and SLS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 3 TA indicator(s) are bullish while SLS’s TA Score has 3 bullish TA indicator(s).

  • FULC’s TA Score: 3 bullish, 6 bearish.
  • SLS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, SLS is a better buy in the short-term than FULC.

Price Growth

FULC (@Biotechnology) experienced а -12.31% price change this week, while SLS (@Biotechnology) price change was -2.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.56%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +1233.13%.

Reported Earning Dates

FULC is expected to report earnings on Aug 07, 2024.

SLS is expected to report earnings on Aug 08, 2024.

Industries' Descriptions

@Biotechnology (-5.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FULC with price predictions.
OPEN
A.I.dvisor published
a Summary for SLS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FULC($460M) has a higher market cap than SLS($76.5M). SLS YTD gains are higher at: 28.302 vs. FULC (9.778).
FULCSLSFULC / SLS
Capitalization460M76.5M601%
EBITDAN/AN/A-
Gain YTD9.77828.30235%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SLS: Fundamental Ratings
SLS
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCSLS
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
79%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
FULCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SLSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTSI99.852.34
+2.40%
MACOM Technology Solutions Holdings
GPCR37.820.17
+0.45%
Structure Therapeutics
ORGN0.59N/A
+0.12%
Origin Materials
AAPL169.38-3.31
-1.92%
Apple
CRBP41.12-1.60
-3.75%
Corbus Pharmaceuticals Holdings